Appointment of Joint Broker

March 14, 2023

14 March 2023

LungLife AI, Inc.
(the “Company” or “LungLife”)

Appointment of Joint Broker

LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, announces the appointment of Goodbody as the Company's Joint Broker with immediate effect.

Investec Bank plc remains Nominated Adviser and Joint Broker to the Company.

 Click HERE for the full announcement. 


Subscribe for Email Alerts

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

© 2020 LungLIfe AI, Inc.
All rights reserved. LiquidBiopsy is a trademark of LungLife AI, Inc.